Lataa...
Responses in multiple myeloma should be assigned according to serum, not urine, free light chain measurements
The most recent update to the International Myeloma Working Group consensus criteria places a strong emphasis on the need for more sensitive haematological markers of response driven by the success of novel therapies. One such marker is serum free light chain (sFLC) analysis, which was first incorpo...
Tallennettuna:
| Julkaisussa: | Leukemia |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group UK
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6365491/ https://ncbi.nlm.nih.gov/pubmed/30573778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-018-0339-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|